{"title":"基因工程生物疗法在肿瘤学中的应用（文献综述）","authors":"S. Mamedova","doi":"10.12737/2409-3750-2023-9-3-26-32","DOIUrl":null,"url":null,"abstract":"The main advantage of targeted therapy for cancer is the unique ability to mobilize the body's own immune system. Stimulation of the immune response leads to activation of internal protective functions that prevent angiogenesis and apoptosis of cancer cells. In addition, drugs that modify the biological reaction accelerate the process of tissue regeneration and the replacement of pathogenic cells with genetically normal ones.","PeriodicalId":503376,"journal":{"name":"Clinical Medicine and Pharmacology","volume":"20 11","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"GENETICALLY ENGINEERED BIOLOGICAL THERAPY IN ONCOLOGY (literature review)\",\"authors\":\"S. Mamedova\",\"doi\":\"10.12737/2409-3750-2023-9-3-26-32\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The main advantage of targeted therapy for cancer is the unique ability to mobilize the body's own immune system. Stimulation of the immune response leads to activation of internal protective functions that prevent angiogenesis and apoptosis of cancer cells. In addition, drugs that modify the biological reaction accelerate the process of tissue regeneration and the replacement of pathogenic cells with genetically normal ones.\",\"PeriodicalId\":503376,\"journal\":{\"name\":\"Clinical Medicine and Pharmacology\",\"volume\":\"20 11\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Medicine and Pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12737/2409-3750-2023-9-3-26-32\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Medicine and Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12737/2409-3750-2023-9-3-26-32","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
GENETICALLY ENGINEERED BIOLOGICAL THERAPY IN ONCOLOGY (literature review)
The main advantage of targeted therapy for cancer is the unique ability to mobilize the body's own immune system. Stimulation of the immune response leads to activation of internal protective functions that prevent angiogenesis and apoptosis of cancer cells. In addition, drugs that modify the biological reaction accelerate the process of tissue regeneration and the replacement of pathogenic cells with genetically normal ones.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
